arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

PepGen Inc.

PEPG
$2.73 ▼ -0.25 (-8.56%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
23 Visible periods
19 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

PepGen Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $188.9M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -15.9%
FCF / Share $-0.23
Trailing P/E
Price / Book 1.6x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

23-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-17.76M
↑ +41.2%
FCF / Share Free cash flow per share
$-0.23
↑ +68.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
14
Cash Quality
61

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 23 quarters